Ranitidine and Blushing - a phase IV clinical study of FDA data

Summary:

Blushing is reported as a side effect among people who take Ranitidine (ranitidine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Benadryl, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Blushing when taking Ranitidine. It is created by eHealthMe based on reports of 233,168 people who have side effects when taking Ranitidine from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,474 Ranitidine users. Check the latest studies of Ranitidine.

What is Blushing?

Blushing is found to be associated with 3,338 drugs and 2,892 conditions by eHealthMe. Check the latest studies of Blushing.

On Oct, 17, 2025

233,168 people reported to have side effects when taking Ranitidine.
Among them, 1,215 people (0.52%) have Blushing.

Among these 1,215 people:

How long have people been on Ranitidine when they have Blushing? *

What is the gender of people who have Blushing when taking Ranitidine? *

female: 73.82 %
male: 26.18 %

What is the age of people who have Blushing when taking Ranitidine? *

What are other drugs people take besides Ranitidine? *

What are other side effects people have besides Blushing? *

Headache (pain in head): 433 people, 35.64%
Fatigue (feeling of tiredness): 417 people, 34.32%
Nausea (feeling of having an urge to vomit): 393 people, 32.35%
Dyspnea (difficult or laboured breathing): 368 people, 30.29%
Rashes (redness): 322 people, 26.50%
Dizziness: 308 people, 25.35%
Chest Pain: 298 people, 24.53%
Weakness: 244 people, 20.08%
Fever: 232 people, 19.09%
Malaise (a feeling of general discomfort or uneasiness): 232 people, 19.09%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 242 people, 19.92%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 136 people, 11.19%
Breast Cancer: 72 people, 5.93%
High Blood Cholesterol: 67 people, 5.51%
Asthma: 64 people, 5.27%
High Blood Pressure: 50 people, 4.12%
Pain: 50 people, 4.12%
Ovarian Cancer (cancer of ovary): 47 people, 3.87%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 40 people, 3.29%
Breast Cancer Metastatic: 39 people, 3.21%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and have Blushing?

- Check whether Blushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ranitidine:

Ranitidine (234,474 reports)

Blushing treatments and more:

Blushing (117,674 reports)

Common Ranitidine side effects:

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Blushing:

Browse all the drugs that are associated with Blushing:

Blushing (3,338 drugs)

Common conditions associated with Blushing:

Ms hug: 22,392 reports
Lipid disorders: 11,125 reports
Lipoprotein test: 11,039 reports
Reduce cholesterol: 10,836 reports
Lipid profile: 10,700 reports
Lower cholesterol: 10,648 reports
Familial primary pulmonary hypertension: 6,234 reports
High density lipoprotein decreased: 4,574 reports
Hypertension: 3,292 reports
Hbp: 3,262 reports

Browse all the conditions that are associated with Blushing:

Blushing (2,892 conditions)

Drugs similar to Ranitidine and Blushing :

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine (the active ingredients of Ranitidine) and Ranitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.